BioCardia outlines Japan Shonin filing in ~7 months and targets ~19-month path to approval for CardiAMP
BioCardia, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $0.92
-11% in 1d after detection
Post-detection moves
1h
—
1d
-11%
3d
-8.9%
7d
-11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS